PAGLIANO, Pasquale
 Distribuzione geografica
Continente #
AS - Asia 9.187
NA - Nord America 5.418
EU - Europa 2.709
SA - Sud America 683
Continente sconosciuto - Info sul continente non disponibili 265
AF - Africa 109
OC - Oceania 9
Totale 18.380
Nazione #
HK - Hong Kong 6.393
US - Stati Uniti d'America 5.194
SG - Singapore 1.381
IT - Italia 1.325
BR - Brasile 513
CN - Cina 440
VN - Vietnam 433
RU - Federazione Russa 354
DE - Germania 247
FR - Francia 151
IE - Irlanda 135
FI - Finlandia 104
CA - Canada 97
KR - Corea 97
GB - Regno Unito 87
IN - India 87
AR - Argentina 72
NL - Olanda 72
BD - Bangladesh 70
UA - Ucraina 52
MX - Messico 49
TR - Turchia 47
IQ - Iraq 41
SE - Svezia 35
AT - Austria 33
ID - Indonesia 32
ZA - Sudafrica 31
VE - Venezuela 27
PK - Pakistan 25
ES - Italia 24
JP - Giappone 22
PL - Polonia 22
EC - Ecuador 21
CZ - Repubblica Ceca 20
CO - Colombia 19
UZ - Uzbekistan 16
MY - Malesia 14
JM - Giamaica 13
SA - Arabia Saudita 13
CR - Costa Rica 12
MA - Marocco 12
CL - Cile 11
KE - Kenya 11
LT - Lituania 9
NI - Nicaragua 9
PH - Filippine 9
TN - Tunisia 9
EG - Egitto 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
UY - Uruguay 7
AU - Australia 6
AZ - Azerbaigian 6
HN - Honduras 6
JO - Giordania 6
AO - Angola 5
IR - Iran 5
LB - Libano 5
PA - Panama 5
PE - Perù 5
RO - Romania 5
AL - Albania 4
BB - Barbados 4
CU - Cuba 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
MD - Moldavia 4
OM - Oman 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
CH - Svizzera 2
KG - Kirghizistan 2
KW - Kuwait 2
PR - Porto Rico 2
PT - Portogallo 2
TH - Thailandia 2
TZ - Tanzania 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AI - Anguilla 1
BF - Burkina Faso 1
BS - Bahamas 1
Totale 18.078
Città #
Hong Kong 6.379
San Jose 934
Singapore 624
Milan 437
Ashburn 413
Council Bluffs 324
Dallas 311
Princeton 309
Chandler 267
Ann Arbor 205
Munich 168
Rome 161
Naples 153
Lauterbourg 133
Ho Chi Minh City 130
The Dalles 124
Beijing 122
Dublin 121
New York 115
Los Angeles 100
Hanoi 89
Santa Clara 89
Moscow 86
Wilmington 80
São Paulo 57
Helsinki 53
Andover 49
Dong Ket 48
Phoenix 46
Figino 45
Brooklyn 42
Jacksonville 42
Woodbridge 41
Redwood City 39
Turku 37
Boardman 33
Houston 33
Salerno 31
Fisciano 25
Nuremberg 25
Denver 24
San Francisco 24
Amsterdam 23
Montreal 22
Orem 22
Toronto 22
Warsaw 22
Tokyo 21
Vienna 21
Columbus 20
Frankfurt am Main 20
Izmir 20
Mexico City 20
Seattle 20
Haiphong 19
London 19
Stockholm 19
Washington 19
Brno 18
Chicago 18
Johannesburg 18
St Petersburg 17
Atlanta 16
Chennai 16
Memphis 16
Poplar 16
Pune 16
Rio de Janeiro 16
Buffalo 15
Charlotte 15
Da Nang 15
Tashkent 15
Baghdad 14
Belo Horizonte 14
Boston 14
Las Vegas 13
Norwalk 13
Turin 13
Newark 12
Sarno 12
Biên Hòa 11
Shanghai 11
Brasília 10
Buenos Aires 10
Caracas 10
Fairfield 10
Jakarta 10
Mercato San Severino 10
Bologna 9
Lappeenranta 9
Managua 9
Milwaukee 9
Nairobi 9
Palermo 9
Queens 9
Salvador 9
Valencia 9
Ankara 8
Avellino 8
Gatchina 8
Totale 13.416
Nome #
Nasopharyngeal virome analysis of COVID-19 patients during three different waves in Campania region of Italy 995
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 909
Eco-friendly synthesis of silver nanoparticles from peel and juice C. limon and their antiviral efficacy against HSV-1 and SARS-CoV-2 641
Listeria monocytogenes meningitis in the elderly: Distinctive characteristics of the clinical and laboratory presentation 594
Plasma miR-1-3p levels predict severity in hospitalized COVID- 19 patients 590
Burden of fungal meningitis 555
Adverse Events Associated with BNT162b2 and AZD1222 Vaccines in the Real World: Surveillance Report in a Single Italian Vaccine Center 492
Infections causing stroke or stroke-like syndromes 439
Impact of ESKAPE Pathogens on Bacteremia: A Three-Year Surveillance Study at a Major Hospital in Southern Italy 387
An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19) 344
Bilateral facial palsy after COVID-19 vaccination 340
HIV and Drug-Resistant Subtypes 327
Gender Differences Associated with the Prognostic Value of BPIFB4 in COVID-19 Patients: A Single-Center Preliminary Study 243
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy) 239
Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality 222
European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults 209
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 196
Continuous Antibiotic Therapy Can Reduce Recurrence of Prosthetic Joint Infection in Patients Undergoing 2-Stage Exchange 190
Hot topics in diabetic foot infection 175
BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19 172
NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy 170
Bacterial meningitis complicating the course of liver cirrhosis 164
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 163
Experimental Pharmacotherapy for COVID-19: The Latest Advances 162
Trend of Bacterial Uropathogens and Their Susceptibility Pattern: Study of Single Academic High-Volume Center in Italy (2015–2019) 158
Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: A comparison of two time periods 151
Changes in the Lipid Asset of HIV/HCV Patients after a Successful Course of Direct-Acting Antivirals 148
Listeria monocytogenes meningitis in the elderly: Epidemiological, clinical and therapeutic findings 144
Factors related to outcome of early and delayed prosthetic joint infections. 143
Visceral leishmaniasis in immunocompromised: Diagnostic and therapeutic approach and evaluation of the recently released IDSA guidelines 142
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 140
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis 138
HIV positive patient with HSV-2 encephalitis: case report 136
Influence of Mycobiota in the Nasopharyngeal Tract of COVID-19 Patients 130
Antimicrobial Susceptibility Profiles of Klebsiella pneumoniae Strains Collected from Clinical Samples in a Hospital in Southern Italy 127
Sepsis and septic shock: New definitions, new diagnostic and therapeutic approaches 119
Drug-Drug Interactions Between HIV Antivirals and Concomitant Drugs in HIV Patients: What We Know and What We Need to Know 118
PD-L1 Dysregulation in COVID-19 Patients 118
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches 116
Postbiotics versus probiotics in early-onset colorectal cancer 116
Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts 115
Clinical and prognostic features of prosthetic joint infections caused by Enterococcus spp 114
Visceral leishamiosis in immunocompromised host: an update and literature review. 113
Epigenetic and Genetic Keys to Fight HPV-Related Cancers 112
Hot topics on vertebral osteomyelitis from the International Society of Antimicrobial Chemotherapy 110
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 107
Lower respiratory tract pathogens and their antimicrobial susceptibility pattern: A 5-year study 106
Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants 105
Emerging antibiotic resistance: carbapenemase-producing enterobacteria. New bad bugs, still no new drugs 105
Alteration of liver biomarkers in patients with SARS-CoV-2 (COVID-19) 103
Characteristics of meningitis following transsphenoidal endoscopic surgery: a case series and a systematic literature review 102
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 100
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 99
COVID-19: a confirmed case of reinfection in a nurse 99
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 98
Antibiotic therapy for pan-drug-resistant infections 98
Oral Therapy, Microbiological Findings, and Comorbidity Influence the Outcome of Prosthetic Joint Infections Undergoing 2-Stage Exchange. 91
Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis 91
KL-6 in ARDS and COVID-19 Patients 86
Acute hepatitis (Non Hepa A-E) of unknown origin among pediatrics 85
Repurposing the Antibacterial Activity of the Drug Teniposide Against Gram-Positive Bacteria 84
Brainstem variant of posterior reversible encephalopathy syndrome: A case report 84
The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19) 82
Distinguishing visceral leishmaniasis from intolerance to pegylated interferon-alpha in a thalassemic splenectomized patient treated for chronic hepatitis C 82
West Nile Virus diffusion in temperate regions and climate change. A systematic review 79
Nonsurgical management of multiple splenic abscesses in an obese patient that underwent laparoscopic sleeve gastrectomy: case report and review of literature 79
Clinical and microbiological outcomes in haematogenous spondylodiscitis treated conservatively 79
Panton–Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy 78
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 77
Skin and soft tissue infections 77
Pharmacological Approaches to Visceral Leishmaniasis in Patients with Immunocompromised Status 76
Corrigendum to ‘Panton-Valentine Leucocidin (PVL) Staphylococcus aureus a position statement from the International Society of Chemotherapy’ [International Journal of Antimicrobial Agents 51/1 (2018) 16-25] 76
Prevalence and Antimicrobial Resistance of Causative Agents to Ocular Infections 76
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices 75
Four cases of meningitis by streptococci other than pneumoniae in adults: clinical and microbiological features 75
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 74
Pulmonary aspergillosis with possible cerebral involvement in a previously healthy pregnant woman 74
Sepsis—A retrospective cohort study of bloodstream infections 74
Natural Health Products in the Prevention and Management of Alzheimer’s Disease: A Systematic Review of Randomized Clinical Trials 73
A case of acute myocarditis associated with Chlamydia trachomatis infection: role of cardiac MRI in the clinical management 73
Is Hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19? 73
Post-arthroscopic septic arthritis of the knee. Analysis of the outcome after treatment in a case series and systematic literature review 72
Epidemiology and treatment of the commonest form of listeriosis: meningitis and bacteraemia 71
The clinical features, diagnosis, treatment, and prognosis of neuroinvasive listeriosis: a multinational study 71
Update on treatment of COVID-19: ongoing studies between promising and disappointing results 70
Hepatitis B virus–induced hepatocarcinogenesis: A virological and oncological perspective 69
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study 68
Corrigendum to ‘Panton-Valentine Leucocidin (PVL) Staphylococcus aureus a position statement from the International Society of Chemotherapy’ [International Journal of Antimicrobial Agents 51/1 (2018) 16-25](S0924857917303941)(10.1016/j.ijantimicag.2017.11.002) 68
Peoples??? attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries 67
Impact of therapeutic choices on outcome of osteomyelitis caused by MRSA 67
Protection and disinfection policies against SARS-CoV-2 (COVID-19) 67
Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease 67
Prevalence and antimicrobial resistance of enterococcus species: A retrospective cohort study in Italy 67
Synovial Cell Count Before Reimplantation Can Predict the Outcome of Patients with Periprosthetic Knee Infections Undergoing Two-stage Exchange 65
Visceral leishmaniasis causes fever and decompensation in patients with cirrhosis 65
Comment: "Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis" 65
RELEASE OF GENTAMICIN FROM CEMENT SPACERS IN TWO-STAGE PROCEDURES FOR HIP AND KNEE PROSTHETIC INFECTION: AN IN VIVO PHARMACOKINETIC STUDY WITH CLINICAL FOLLOW-UP 64
Toscana virus central nervous system infections in southern Italy 63
Factors influencing the presentation and outcome of tuberculous meningitis in childhood 62
The combined evaluation of fibrinogen and D-dimer levels are a helpful tool to exclude periprosthetic knee infection 62
Totale 15.991
Categoria #
all - tutte 59.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022558 0 0 0 6 10 6 10 22 171 27 77 229
2022/2023794 86 63 98 64 79 162 19 63 91 5 47 17
2023/2024555 28 51 32 29 33 85 43 23 14 43 36 138
2024/20251.818 38 21 34 106 76 196 304 152 328 103 193 267
2025/202612.091 1.841 2.852 2.468 557 838 351 1.036 242 337 693 168 708
2026/20271.813 268 276 774 495 0 0 0 0 0 0 0 0
Totale 18.380